skip to main content
Idioma:
Resultados 1 2 3 next page
Mostrar Somente
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer
Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer

Page, David B. ; Hong, Erin ; Kaur, Lakhvir ; Gauntt, Sarah ; Gedney, Holley ; Hobbs, Evthokia ; Perlewitz, Kelly Shea ; Seino, Amanda ; Topp, Zheng Zhu ; Conlin, Alison Katherine

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.12141-12141 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
2
Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)
Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of 27-gene IO score with outcome in a phase Ib trial of pembrolizumab (pembro) plus chemotherapy (CT) in metastatic triple-negative breast cancer (mTNBC)

Page, David B. ; Collins, Krystle Louise ; Rajamanickam, Venkatesh ; Moxon, Nicole ; Mellinger, Staci L. ; Conlin, Alison Katherine ; Seitz, Robert ; McGregor, Kim ; Nielsen, Tyler J. ; McArthur, Heather L.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1082-1082 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)
Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant survivin-targeted immunotherapy maveropepimut-S (MVP-S) to increase Th1 immune response in Ki67-high hormone receptor-positive (HR+) early-stage breast cancer (ESBC)

Stanton, Sasha E. ; MacDonald, Lisa Diana ; Mellinger, Staci L. ; Moxon, Nicole ; Kelly, Tracy ; Hirsch, Heather Anne ; Fiset, Stephan ; Young, Kristina Hoot ; Page, David B.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS1119-TPS1119 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)
NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

NeoIRX trial: Immunologic induction with peri-lymphatic cytokines to enhance pembrolizumab (pembro) response in stage II/III triple-negative breast cancer (TNBC)

Page, David B. ; Su, Alan ; Moxon, Nicole ; Mellinger, Staci L. ; Kelly, Tracy ; Conlin, Alison Katherine ; Topp, Zheng Zhu ; Newell, Pippa ; Fredrich, Nicole ; Massimino, Kristen P. ; Wu, Yaping ; Redmond, William L ; Aliabadi, Shaghayegh ; Sun, Zhaoyu ; Imatani, James ; Stanton, Sasha E.

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.604-604 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant HER2-targeted therapy ± immunotherapy with pembrolizumab (neoHIP): An open label randomized phase II trial

McArthur, Heather L. ; Leal, Jorge ; Shiao, Stephen Lawrence ; Carter, Meredith ; Basho, Reva K ; Phillips, Michelle ; Chan, David ; Hool, Hugo ; Park, Dorothy J. ; El-Masry, Mary ; McAndrew, Philomena ; Sikaria, Swati ; Spring, Laura ; Bardia, Aditya ; Tighiouart, Mourad ; Dadmanesh, Farnaz ; Giuliano, Armando E. ; Sanchez, Katherine ; Page, David B.

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS634-TPS634 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy
Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor infiltrating lymphocyte recruitment in patients with early stage breast cancer after intramammary IRX-2 cytokine immunotherapy

Page, David B. ; Pucilowska, Joanna ; Berinstein, Neil Lorne ; Egan, James E.

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.7-7 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer

McArthur, Heather L. ; Comen, Elizabeth Anne ; Bryce, Yolanda ; Solomon, Stephen Barnett ; Leal, Jorge Henrique S. ; Abaya, Christina DiLauro ; Martinez, Cristal ; Basho, Reva K ; McAndrew, Philomena ; Larkin, Brigid ; Page, David B. ; Mellinger, Staci L. ; Fredrich, Nicole ; Moxon, Nicole ; Reddy, Sangeetha M. ; Carter, Meredith ; Patil, Sujata ; Dogan, Basak ; Gatti-Mays, Margaret Elena ; Norton, Larry

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS635-TPS635 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial
Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open-label randomized phase II trial

McArthur, Heather L. ; Leal, Jorge Henrique S. ; Page, David B. ; Abaya, Christina DiLauro ; Basho, Reva K ; Phillips, Michelle ; Chan, David ; Hool, Hugo ; Park, Dorothy J. ; El-Masry, Mary ; McAndrew, Philomena ; Sikaria, Swati ; Spring, Laura ; Bardia, Aditya ; Tighiouart, Mourad ; Dadmanesh, Farnaz ; Giuliano, Armando E. ; Shiao, Stephen Lawrence

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS624-TPS624 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
TAK-676 in combination with pembrolizumab after radiation therapy in patients (pts) with advanced non–small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), or squamous-cell carcinoma of the head and neck (SCCHN): Phase 1 study design
TAK-676 in combination with pembrolizumab after radiation therapy in patients (pts) with advanced non–small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), or squamous-cell carcinoma of the head and neck (SCCHN): Phase 1 study design
Material Type:
Artigo 		Adicionar ao Meu Espaço

TAK-676 in combination with pembrolizumab after radiation therapy in patients (pts) with advanced non–small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), or squamous-cell carcinoma of the head and neck (SCCHN): Phase 1 study design

Cooper, Benjamin T. ; Chmura, Steven J. ; Luke, Jason J. ; Shiao, Stephen Lawrence ; Basho, Reva K ; Iams, Wade Thomas ; Page, David B. ; Li, Cong ; Gregory, Richard C. ; Shaw, Michael ; Horn, Kristin ; Gibbs, John ; Appleman, Vicky A. ; Berger, Allison J. ; Abu-Yousif, Adnan ; Lineberry, Neil ; Stumpo, Kate ; Elfiky, Aymen ; Gerber, Naamit Kurshan

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2698-TPS2698 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer

McArthur, Heather L. ; Comen, Elizabeth Anne ; Bryce, Yolanda ; Solomon, Stephen Barnett ; Leal, Jorge Henrique S. ; Abaya, Christina DiLauro ; Martinez, Cristal ; Basho, Reva K ; Park, Dorothy J. ; McAndrew, Philomena ; Larkin, Brigid ; Mills, William ; Page, David B. ; Mellinger, Staci L. ; Fredrich, Nicole ; Moxon, Nicole ; Reddy, Sangeetha M. ; Carter, Meredith ; Patil, Sujata ; Norton, Larry

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS617-TPS617 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.